Pilot Study on Antibiotic-Loaded Ceramic Implant Launched

I.CERAM, a company specializing in biocompatible ceramic implants, has initiated a pilot clinical study in partnership with Pitié-Salpêtrière Hospital in Paris. This study aims to evaluate an antibiotic-loaded Porous Ceramic Sternal Stabilisation Implant, under the supervision of Professor Pascal Leprince, Head of the Cardiac Surgery Department.

The innovative implant, part of the S 2OP2CI project, is designed to stabilize the chest wall post-surgery and prevent bacterial contamination, which can complicate recovery. This pilot study involves ten implantations to assess the benefits of this technology. Mediastinitis, a postoperative complication, remains a serious concern and this study may contribute significantly to reducing associated risks.

Professor Leprince aims to address critical postoperative challenges through this study, which aligns with his department's reputation for excellence in cardiac surgery.